Retinal Clinical Assessment With AI-derived Quantitative Information

NCT ID: NCT07291960

Last Updated: 2025-12-18

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Total Enrollment

21 participants

Study Classification

OBSERVATIONAL

Study Start Date

2025-12-15

Study Completion Date

2026-01-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This randomized controlled trial evaluates whether providing clinicians with AI-derived quantitative retinal information improves the quality and efficiency of retinal clinical assessment. Participating ophthalmologists and ophthalmology trainees will be randomly assigned to one of two groups. The intervention group will write clinical reports with access to automated quantitative measurements generated from fundus image analysis, including multiple retinal structural and vascular biomarkers. The control group will complete the same reporting tasks using only the original fundus images without AI-generated quantitative information.

All reports produced by both groups will be de-identified and independently evaluated by a separate panel of senior ophthalmologists who are blinded to group allocation. The expert evaluators will assess report accuracy, completeness, clarity, and overall clinical quality using predefined scoring criteria. The study aims to determine whether access to quantitative retinal biomarkers enhances clinicians' reporting performance and reduces reporting time during retinal assessment tasks.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

no Obvious Abnormalities Diabetic Retinopathy (DR) AMD Cup-to-disc Ratio Bigger Than 0.5 Pathological Myopia Macular Hole Epiretinal Membrane Retinal Vein Occlusion (RVO)

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

AI-derived retinal quantification

AI-derived retinal quantitative information-assisted reporting

Intervention Type DIAGNOSTIC_TEST

Clinicians assigned to the intervention arm will complete retinal clinical reports with access to an AI system that provides automated retinal feature quantification. The system generates multiple quantitative retinal biomarkers-including vessel characteristics, optic nerve head metrics, macular indices, and other region-specific structural measurements-derived from automated segmentation of each fundus image.

During report writing, clinicians can view these AI-generated quantitative values alongside the image. The system does not provide diagnostic labels, impressions, or textual interpretations; it only supplies numerical measurements intended to support clinicians' assessment. All clinical judgments, narrative descriptions, and final conclusions in the report are made solely by the clinician.

Routine clinical interpretation

No interventions assigned to this group

Outcome Assessor

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

AI-derived retinal quantitative information-assisted reporting

Clinicians assigned to the intervention arm will complete retinal clinical reports with access to an AI system that provides automated retinal feature quantification. The system generates multiple quantitative retinal biomarkers-including vessel characteristics, optic nerve head metrics, macular indices, and other region-specific structural measurements-derived from automated segmentation of each fundus image.

During report writing, clinicians can view these AI-generated quantitative values alongside the image. The system does not provide diagnostic labels, impressions, or textual interpretations; it only supplies numerical measurements intended to support clinicians' assessment. All clinical judgments, narrative descriptions, and final conclusions in the report are made solely by the clinician.

Intervention Type DIAGNOSTIC_TEST

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

Clinician Participants (Report Writers)

1. Board-certified ophthalmologists or ophthalmology trainees (registrars or fellows) with clinical experience in interpreting fundus images.
2. Capable of independently completing retinal clinical reports based on fundus photography.
3. Willing and able to participate in the study tasks (report writing) under assigned study conditions.
4. Able to provide informed consent.

Expert Evaluators (Outcome Assessors)

1. Senior ophthalmologists with at least 5 years of post-certification clinical experience.
2. Not involved in the report-writing stage of the study.
3. Willing to evaluate de-identified reports across predefined quality dimensions.
4. Able to provide informed consent.

Fundus Images (Data Inputs)

1. Retinal fundus photographs of sufficient quality for clinical interpretation.
2. Images representing a range of common retinal findings (normal or abnormal).
3. Previously collected, de-identified images with no patient-identifiable information.

Exclusion Criteria

Clinician Participants

1. Lack of experience in interpreting fundus images (e.g., interns, medical students).
2. Prior involvement in the development, training, or validation of the AI system being tested.
3. Inability to complete reporting tasks due to time constraints or technical limitations.
4. Any condition that may interfere with ability to perform study tasks (e.g., prolonged absence).

Expert Evaluators

1. Participation in the intervention or control reporting arms.
2. Prior exposure to or involvement in development of the AI system.
3. Any conflict of interest affecting impartiality of report quality evaluation.

Fundus Images

1. Poor-quality images with insufficient clarity for interpretation.
2. Images containing artifacts or cropping that prevent accurate segmentation or assessment.
3. Images with any remaining patient identifiers (excluded to maintain confidentiality).
Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Beijing Tongren Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

TRECK2018-056-GZ(2022)-07

Identifier Type: -

Identifier Source: org_study_id